Zosano Pharma Corp
NASDAQ:ZSAN
Zosano Pharma Corp
Cash from Financing Activities
Zosano Pharma Corp
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zosano Pharma Corp
NASDAQ:ZSAN
|
Cash from Financing Activities
$17.6m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.5B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-25%
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Zosano Pharma Corp's Cash from Financing Activities?
Cash from Financing Activities
17.6m
USD
Based on the financial report for Mar 31, 2022, Zosano Pharma Corp's Cash from Financing Activities amounts to 17.6m USD.
What is Zosano Pharma Corp's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-12%
Over the last year, the Cash from Financing Activities growth was -64%. The average annual Cash from Financing Activities growth rates for Zosano Pharma Corp have been -28% over the past three years , -12% over the past five years .